CXCR4-Antagonist: Plerixafor verbessert die Mobilisierung in der autologen hämatopoetischen Stammzelltransplantation

Publisher： Karger

E-ISSN： 2296-5262|33|10|560-560

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.10, 2010-09, pp. : 560-560

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cetuximab verbessert die Wirksamkeit der Chemotherapie in allen Therapielinien

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 668-669

Karger

Access to resources Recommend Favorite

A Lentiviral CXCR4 Overexpression and Knockdown Model in Colorectal Cancer Cell Lines Reveals Plerixafor-Dependent Suppression of SDF-1α-Induced Migration and Invasion

By  

Oncology Research and Treatment, Vol. 34, Iss. 10, 2011-09 ,pp. : 502-508

Karger

Access to resources Recommend Favorite

The BCL2 antagonist ABT‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4Wild‐type and CXCR4WHIM mutated Waldenstrom macroglobulinaemia cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 1, 2015-07 ,pp. : 134-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

CPAP-Anwendung verbessert die Oxygenierung in normobarer und hypobarer Hypoxie

By Koch Robert  

Wiener Medizinische Wochenschrift, Vol. 158, Iss. 5-6, 2008-03 ,pp. : 156-159

Springer Publishing Company

Access to resources Recommend Favorite

CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 6, 2015-06 ,pp. : 1855-1867

John Wiley & Sons Inc

Access to resources Recommend Favorite